4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-23-012352
Chief Financial Officer gave up 683 shares (to pay taxes)
- Chief Financial Officer acquired 1,752 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jeanmonod Patrik Chief Financial Officer | 2023-02-21 | Option exercise | +1,752 | 117,884 | D | ||
| Jeanmonod Patrik Chief Financial Officer | 2023-02-21 | Shares withheld for taxes | −683 | $10.97 | $7,493 | 117,201 | D |
| Derivatives | |||||||
| Jeanmonod Patrik Chief Financial Officer | 2023-02-21 | Option exercise · Restricted Stock Units | −1,752 | 20,450 | D | ||
Loading xslF345X03/doc4.xml…